Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Gabai

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Oncotarget|February 11, 2015
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agentMaria Giovanna Sabbieti, Dimitrios Agas, Melania Capitani, et al.
Oncotarget|October 10, 2014
Pilot study of p62 DNA vaccine in dogs with mammary tumorsVladimir Gabai, Franco M Venanzi, Elena Bagashova, et al.
Frontiers in Veterinary Science|June 23, 2025
Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot studyVladimir Gabai, Evgeny Bakin, Maxim Langs, et al.
Research Square|November 28, 2024
Efficacy of p62-expressing plasmid in treatment of canine osteoarthritisVladimir Gabai, Evgeny Bakin, Maxim Harold Langs, et al.
Oncotarget|October 15, 2013
Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vectorFranco Venanzi, Victor Shifrin, Michael Sherman, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Oncotarget|February 11, 2015
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agentMaria Giovanna Sabbieti, Dimitrios Agas, Melania Capitani, et al.
Oncotarget|October 10, 2014
Pilot study of p62 DNA vaccine in dogs with mammary tumorsVladimir Gabai, Franco M Venanzi, Elena Bagashova, et al.
Frontiers in Veterinary Science|June 23, 2025
Efficacy of P62-expressing plasmid in treatment of canine osteoarthritis pain: a pilot studyVladimir Gabai, Evgeny Bakin, Maxim Langs, et al.
Research Square|November 28, 2024
Efficacy of p62-expressing plasmid in treatment of canine osteoarthritisVladimir Gabai, Evgeny Bakin, Maxim Harold Langs, et al.
Oncotarget|October 15, 2013
Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vectorFranco Venanzi, Victor Shifrin, Michael Sherman, et al.
Pageof 2